EuroEyes International Eye Clinic Limited (1846) AI Stock Analysis

• Market Cap: HK$863.39M
• Dividend Yield: 1.99%
• Average Volume (3M): 156.72K
• Price to Earnings (P/E): 5.7
• Beta (1Y): 0.24
• Revenue Growth: -1.61%
• EPS Growth: -27.39%
• Country: HK
• Employees: 322
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 320,706,000
• 10 Day Avg. Volume: 164,000
• 30 Day Avg. Volume: 156,720
• PEG Ratio: -0.42
• Price to Book (P/B): 1.19
• Price to Sales (P/S): 1.82
• P/FCF Ratio: 11.11
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 69 Neutral
• Price Target: HK$3.00 ▲(0.00% Upside)
• Action: Reiterated Date: 10/22/25
• Date: Action: Reiterated 10/22/25

The overall stock score reflects strong financial stability and reasonable valuation, offset by concerns about declining profit margins and missing cash flow data. Technical indicators suggest neutral market momentum, neither strongly positive nor negative.

Positive Factors

Specialized multi-country clinical platform

EuroEyes' focused clinical model—laser, cataract and corrective services delivered via experienced clinicians and advanced tech—creates durable demand and high service specialization. Multi-country presence diversifies patient flow and referral networks, supporting stable long-term revenue generation and scale benefits.

Negative Factors

Eroding gross and net profit margins

Material margin compression signals rising direct costs or pricing pressure and, if persistent, will reduce cash available for reinvestment and growth. Shrinking margins can impair ability to fund technology upgrades, marketing, or expansion, weakening long-term return on invested capital.

EuroEyes International Eye Clinic Limited Business Overview & Revenue Model

Company Description

EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery...

Read more

EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery...

How the Company Makes Money

EuroEyes generates revenue primarily through the provision of surgical procedures, including LASIK, cataract surgery, and other corrective eye treatments. The company charges patients for these services, which typically include pre-operative consu...

Read more

EuroEyes generates revenue primarily through the provision of surgical procedures, including LASIK, cataract surgery, and other corrective eye treatments. The company charges patients for these services, which typically include pre-operative consu...

EuroEyes International Eye Clinic Limited Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	724.43M	715.68M	714.29M	610.29M	632.93M	473.82M
Gross Profit	295.40M	286.59M	335.52M	270.84M	312.55M	214.10M
EBITDA	149.21M	141.89M	292.10M	220.44M	278.80M	173.62M
Net Income	76.53M	82.28M	131.24M	89.47M	133.56M	65.58M
Balance Sheet
Total Assets	1.81B	1.60B	1.75B	1.54B	1.37B	1.31B
Cash, Cash Equivalents and Short-Term Investments	769.46M	653.23M	720.38M	779.57M	861.58M	761.89M
Total Debt	345.45M	319.29M	384.26M	290.41M	221.48M	239.55M
Total Liabilities	512.51M	473.72M	588.09M	497.95M	328.55M	324.57M
Stockholders Equity	1.26B	1.09B	1.13B	1.01B	1.01B	953.29M
Cash Flow
Free Cash Flow	131.44M	117.41M	102.30M	152.46M	228.71M	40.12M
Operating Cash Flow	196.36M	197.75M	191.85M	208.76M	273.26M	78.46M
Investing Cash Flow	-65.24M	-83.83M	-180.28M	-131.81M	-59.90M	-38.13M
Financing Cash Flow	-144.70M	-136.82M	-102.76M	-102.22M	-69.18M	-116.37M

EuroEyes International Eye Clinic Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1846, the sentiment is Negative. The current price of 3 is above the 20-day moving average (MA) of 2.78, above the 50-day MA of 2.86, and below the 200-day MA of 3.04, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 41.07 is Neutral, neither overbought nor oversold. The STOCH value of 49.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1846.

EuroEyes International Eye Clinic Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3689	71 Outperform	HK$678.82M	3.30	5.29%	9.14%	0.47%	50.46%
1846	69 Neutral	HK$863.39M	5.69	6.49%	1.99%	-1.61%	-27.39%
2219	68 Neutral	HK$1.94B	4.06	7.38%	9.29%	-3.19%	-20.30%
6639	60 Neutral	HK$1.03B	39.67	1.27%	―	-4.30%	13.83%
3869	56 Neutral	HK$545.87M	5.00	31.63%	―	2.30%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
3309	47 Neutral	HK$1.61B	20.66	5.64%	1.20%	2.05%	-285.88%

EuroEyes International Eye Clinic Limited Corporate Events